Fern Gene

À propos de Fern Gene

Plateforme local-first d'interprétation continue des données génomiques

What we are

Fern Gene is not a sequencing service. We are the interpretation layer that sits between your raw genomic files and actionable health guidance. Sequencing labs deliver data; we deliver continuous understanding.

Local-first by architecture, not policy

Your raw files never leave your device. This is not a privacy policy that can change — it is a structural property of our architecture. Analysis runs on your phone or computer. No cloud upload. No server-side processing of raw data.

Regulatory alignment

Local-first processing naturally aligns with China's Human Genetic Resources Management Regulations, GDPR data residency requirements, and CCPA data minimization principles. When data never leaves your device, cross-border transfer and data breach risks are structurally eliminated.

Evidence-based rule engine

1,185 production rules across 17 interpretation areas, built on ClinGen, ClinVar, PharmGKB, CPIC, GWAS Catalog, and professional guidelines from ACMG and NCCN. Each result links to its evidence source. The rule engine updates through cryptographically signed packages — your genome gets re-interpreted as research evolves.

Our mission

Make genomic data a living asset for every family. Not a static report filed away — but a continuously updated resource that grows more valuable every year, across every life stage, for every family member.

By the numbers

Technical capabilities backed by institutional partnerships.

400+

Medical institution partnerships

10+

Evidence sources integrated

32

PhD-level researchers

5

Industry segments covered

3

International pharma partnerships

1,185

Production rules in engine

Institutional partnerships

Collaborations that validate our technical foundation.

  • National Cancer Center · National Respiratory Medicine Center
  • AstraZeneca — sole APAC data service provider for drug target discovery
  • PerkinElmer · Roche · Thermo Fisher — equipment R&D partnerships
  • Harbin Institute of Technology · Chongqing University — joint research institutes

Recognized excellence

Industry recognition and certifications.

  • Frost & Sullivan Asia-Pacific Digital Gene Testing Leadership Award
  • "Future Healthcare 100" recognition
  • "Specialized & New" enterprise certification
  • Technical Innovation Demonstration Enterprise
  • Provincial Enterprise Technology Center

Technology platform

Proprietary technology powering every analysis.

AI Diagnostics Platform

GenVista Platform powers automated variant interpretation with production-grade AI diagnostics. 17 interpretation areas running simultaneously.

Medical AI assistant

On-device medical large language model provides natural language explanations of genomic results, medication interactions, and follow-up priorities.

Automated production pipeline

Fully automated PCR production line ensures consistent quality for sample processing. Clinical-grade infrastructure behind every analysis.